Novel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies 2022

Date & Location

Wednesday, November 2, 2022, 7:50 AM - 5:40 PM, Online, New York, NY

Specialties

Overview

Novel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies Hematopoietic stem cell transplant (HSCT) and cellular therapy is a hyper-specialized field within the already specialized pediatric oncology world. This necessitates providers to stay current on the rapidly evolving science behind the care of these complex patients.

This one-day symposium will have a focus on topics curated for advanced practice providers, including a mix of foundations of HSCT in addition to current clinical developments in the field. 

The focused topics will include advances in GVHD therapies, unique disease processes that are being transplanted more often in the current era, diagnostic findings of HSCT complications, and new clinical trials that our patients are undergoing including JSP for SCID, TCR modified T-cell therapy for sarcoma patients and expanded cord blood transplant for multiply relapsed leukemia.

Who Should Attend

This symposium is intended for advanced practice providers who will be caring primarily or be involved in the care of pediatric hemopoietic stem cell transplant patients.

 

 

 Topics:

• Advances in Treatment of acute GVHD.mp4
• Advances in Treatment of acute GVHD.pdf
• APP-Peds-BMT-brochure.pdf
• Bone Marrow Failure Syndromes Fanconi Anemia.mp4
• Bone Marrow Failure Syndromes Fanconi Anemia.pdf
• Complications from HSCT Q&A.mp4
• Conditioning Regimens Graft Sources.mp4
• Conditioning Regimens Graft Sources.pdf
• Dermatology Presentation and Treatment Markova.mp4
• Dermatology Presentation and Treatment Markova.pdf
• Dermatology Presentation and Treatment Queliza.mp4
• Dermatology Presentation and Treatment Queliza.pdf
• Expanded Cord Blood for Relapsed Leukemia.mp4
• Expanded Cord Blood for Relapsed Leukemia.pdf
• Foundations of Pediatric Hematopoetic Stem Cell Transplant (HSCT) and Cell Therapie.mp4
• Foundations of Pediatric Hematopoetic Stem Cell Transplant (HSCT) and Cell Therapie.pdf
• Graft Vs. Host Disease in the Pediatric HSCT Patient Q&A.mp4
• HSCT for Epidermolysis Bullosa and Other Metabolic Syndromes.mp4
• HSCT for Epidermolysis Bullosa and Other Metabolic Syndromes.pdf
• Jasper Antibody for SCID (Severe Compromised Immunodeficiency).mp4
• Jasper Antibody for SCID (Severe Compromised Immunodeficiency).pdf
• Newest Clinical Trials Q&A.mp4
• Patient Perspective – My life after Transplant.mp4
• Patient Perspective – My life after Transplant.pdf
• Post-Transplant Lymphoproliferative Disease (PTLD) and the use of EBV CTLs.mp4
• Post-Transplant Lymphoproliferative Disease (PTLD) and the use of EBV CTLs.pdf
• Pulmonary GVHD Picture.mp4
• Pulmonary GVHD Picture.pdf
• Sickle Cell Disease.mp4
• Sickle Cell Disease.pdf
• Sinusoidal Obstructive Syndrome (SOS)- Radiographic Findings.mp4
• Sinusoidal Obstructive Syndrome (SOS)- Radiographic Findings.pdf
• Starting with Basics Q&A.mp4
• TCR-modified T-cell Therapy.mp4
• TCR-modified T-cell Therapy.pdf
• Transplant Associated Thrombotic Microangiopathy (TMA).mp4
• Transplant Associated Thrombotic Microangiopathy (TMA).pdf
• Transplant for Nonmalignant Diseases Q&A.mp4